Cyclobenzaprine Recalled

On Aug. 27, 2025, Unichem Pharmaceuticals issued a recall for one lot of cyclobenzaprine hydrochloride 10mg tablets due to a labeling error in which bottles labeled as cyclobenzaprine 10mg actually contain meloxicam 7.5mg tablets. Cyclobenzaprine is a muscle relaxant indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions, while meloxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis. Inadvertent administration of meloxicam may result in serious adverse events including cardiovascular, gastrointestinal, renal, anaphylactic, and dermatologic reactions, especially in patients with NSAID allergies, those on anticoagulants, or with underlying comorbidities. Full recall details are available here.